-- Terra Innovatum Global (NKLR) 周三宣布,已与核燃料和合金制造商 Conuar 达成合作协议,旨在推进其 SOLO 反应堆平台规模化部署所需的制造工艺。 该协议的重点在于开发和标准化锆合金和不锈钢结构及功能部件的制造工艺,这些材料对反应堆堆芯的性能至关重要。 Terra 还表示,将利用 Conuar 在锆合金制造方面的专业知识,推进可建造性研究。
Price: $5.85, Change: $-0.49, Percent Change: -7.73%
-- Terra Innovatum Global (NKLR) 周三宣布,已与核燃料和合金制造商 Conuar 达成合作协议,旨在推进其 SOLO 反应堆平台规模化部署所需的制造工艺。 该协议的重点在于开发和标准化锆合金和不锈钢结构及功能部件的制造工艺,这些材料对反应堆堆芯的性能至关重要。 Terra 还表示,将利用 Conuar 在锆合金制造方面的专业知识,推进可建造性研究。
Price: $5.85, Change: $-0.49, Percent Change: -7.73%
Apellis Pharmaceuticals (APLS) has an average rating of hold and mean price target of $40.82, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $40.95, Change: $-0.05, Percent Change: -0.11%
Terns Pharmaceuticals (TERN) has an average rating of hold and mean price target of $53, according to analysts polled by FactSet.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target price by $8 to $196, 19x our 2026 EPS estimate (unchanged) and a discount to its 23x five-year average forward multiple, reflecting geopolitical risks. We lower our 2026 EPS to $10.33 from $10.74 and 2027's to $11.58 from $12.07, primarily reflecting lower gross bookings growth from the Middle East conflict. We maintain our Buy opinion as shares are undervalued given long-term competitive strengths and temporary geopolitical headwinds. The company's Connected Trip platform and Genius loyalty program are supporting higher-margin direct bookings, suggesting AI initiatives are strengthening consumer engagement rather than disintermediating the platform. Strong free cash flow supports future shareholder returns, including $3.6 billion in Q1 buybacks. While the Middle East conflict will impact Q2 bookings, BKNG has a history of seeing travel rebound following geopolitical or economic disruptions. U.S. room night growth accelerated in Q1 to a low-teens range, providing near-term momentum.